Tag: CBT > Aurora Cannabis Canada

Finance

Aurora Cannabis Provides Business Update

The company’s acquisition of Safari Flower and leading European performance are expected to fuel international growth in Q2 and beyond.

September 16, 2026

Mergers and Acquisitions

Curaleaf Sends Letter to Aurora Shareholders

Curaleaf Chairman and CEO Boris Jordan encourages Aurora’s shareholders to tender their shares and become owners of the world’s leading cannabis company.

September 15, 2026

Mergers and Acquisitions

Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From Facts

Aurora claims that Curaleaf’s latest announcement is a ‘desperate’ effort to shift shareholder attention away from a hostile bid that “undervalues’ Aurora.

September 14, 2026

Mergers and Acquisitions

Curaleaf Submits Application to Alberta Securities Commission to Halt Aurora's ATM Program During Pending Offer

The company argues Aurora’s share issuances are an improper and abusive defensive tactic that dilutes shareholders and interferes with the consideration of Curaleaf’s offer.

September 14, 2026

Mergers and Acquisitions

Curaleaf Issues Fact Sheet to Address What It Believes Are Misleading Statements From Aurora

The company’s fact sheet includes more than a dozen “myths” that it says Aurora has focused on while criticizing Curaleaf’s takeover bid.

September 8, 2026

Mergers and Acquisitions

Curaleaf Responds to Aurora Circular; Reaffirms Offer as Best Path to Value Creation for Shareholders

The company’s response comes after Aurora’s board unanimously concluded that the takeover bid is not in the best interests of Aurora or its shareholders.

September 2, 2026

Finance

Aurora Cannabis Urges Shareholders to Reject Curaleaf's Hostile Bid

The company is warning that the Curaleaf bid is inadequate, undervalues Aurora, and puts shareholder value and future upside at risk.

September 2, 2026

Mergers and Acquisitions

Curaleaf Responds to Aurora Cannabis' Latest Attempt to Deflect From Shareholder Value Creation

Aurora’s selective statistics and misleading characterization of engagement do not obscure years of underperformance and lost shareholder value, Curaleaf states.

August 25, 2026

Mergers and Acquisitions

Aurora Cannabis Corrects Inaccurate Statements Made in Support of Curaleaf’s Hostile Bid

Aurora advised its shareholders to take no action regarding the Curaleaf offer at this time.

August 24, 2026

Mergers and Acquisitions

Aurora Cannabis Acquires Internode Pharma, HAP Pharma, Expanding Distribution Access to UK

The acquisitions further Aurora’s global medical cannabis growth.

August 20, 2026

Mergers and Acquisitions

Aurora Cannabis Urges Shareholders to Take No Action on Curaleaf’s Unsolicited Takeover Bid

The company claims Curaleaf’s hostile takeover bid is designed to pressure Aurora’s shareholders into a short-term decision for the benefit of Curaleaf shareholders.

August 19, 2026

Mergers and Acquisitions

Curaleaf Launches Takeover Bid to Acquire Aurora Cannabis, Invites Aurora Shareholders to Tender Bid

The company filed the formal offer and takeover bid circular, which will be delivered to Aurora shareholders.

August 18, 2026